within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BA01_OrganoHeparinoid;
model OrganoHeparinoid 
   extends Pharmacolibrary.Drugs.ATC.C.C05BA01;

  annotation(Documentation(
    info ="<html><body><p>Organo-heparinoid is a synthetic or semi-synthetic derivative of heparin classified as a heparinoid, primarily indicated for the treatment of chronic venous insufficiency, hemorrhoids, and local treatment of thrombophlebitis. It exhibits antithrombotic and anti-inflammatory properties. Usage is generally topical and limited in modern medicine; it is not widely approved as a systemic anticoagulant.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with parameter values found for organo-heparinoid; parameters are not available in primary literature or regulatory sources.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end OrganoHeparinoid;
